Summary
Ten patients were injected with 2 g cefotaxime i. v. The antibacterial activity in the bile was measured by the agar diffusion test and the concentrations of cefotaxime and desacetyl cefotaxime were determined by high performance liquid chromatography. The values found allow the use of cefotaxime in infectious biliary diseases.
Zusammenfassung
Zehn Patienten wurden je 2 g Cefotaxim i. v. injiziert. In der Galleflüssigkeit wurden die antibakterielle Aktivität mittels Agardiffusionstest und die Konzentrationen von Cefotaxim und Desacetyl-Cefotaxim mit Hochdruckflüssigkeitschromatographie bestimmt, Die gefundenen Werte erlauben den Einsatz von Cefotaxim bei infektiösen Gallenwegserkrankungen.
Literature
Kees, F., Strehl, E., Seeger, K., Seidel, G., Dominiak, P., Grobecker, H. Comparative determination of cefotaxime and desacetyl cefotaxime in serum and bile by bioassay and high-performance liquid chromatography. Arzneim.-Forsch. 31 (1981) 362–365.
Brogard, J. M., Comte, F., Pinget, M. Pharmacokinetics of cephalosporin antibiotics. In:Schönfeld, H., Brockmann, R. W., Hahn, F. E. (eds.): Antibiotics and Chemotherapy 25, Karger, Basel 1978, pp. 123–162.
Reeves, D. S., White, L. O., Holt, H. A., Bahari, D., Bywater, M. J., Bax. R. P. Human metabolism of cefotaxime. J. Antimicrob. Chemother. 6 Suppl. A (1980) 93–101.
Bergan, T., Solberg, R. Assay of cefotaxime by high-pressure liquid chromatography. Chemotherapy 27 (1981) 156–165.
Mashimo, K. Penetration of antibiotics into bile. Scand. J. Infect. Dis. Suppl. 14 (1978) 172–176.
Shimizu, K.: Cefoperazone: absorption, excretion, distribution and metabolism. Clin. Ther. 3 Special Issue (1980) 60–79.
Schrinner, E., Limbert, M., Penassel, L., Lutz, A. Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro andin vivo). J. Antimicrob. Chemother. 6 Suppl. A (1980) 25–30.
Wise, R., Wills, P. J., Andrews, J. M., Bredford, K. A. Activity of cefotaxime (HR 756) desacctyl metabolite compared with those of cefotaxime and other cephalosporins. Antimicrob. Agents Chemother. 17 (1980) 84–86.
Strehl, E.: Therapeutische Wirkung neuer Cephalosporine: Mikrobiologische und pharmakologische Untersuchungen. Dissertation Universität Regensburg 1981.
Keighley, M. R. B., Drysdale, R. B., Qoraishi, A. H. Antibiotics in biliary disease: the relative importance of antibiotic concentrations in the bile and serum. Gut 17 (1976) 495–500.
Pyrtek, L. J., Bartus, S. B. An evaluation of antibiotics in biliary tract surgery. Surg. Gynecol. Obstet. 125 (1967) 101–105.
Trachtenberg, L., Fagelman, K. M., Polk, Jr., H. C. The biliary tract kinetics of some cephalosporin antibiotics. Surgery 84 (1978) 342–347.
Bergmann, H. D. Cefamandole. Drug Intell. Clin. Pharm. 13 (1979) 144–149.
Kratochvil, P., Brandstätter, G., Adam, D., Koch, E. Biliäre Elimination von Cefazedon. MMW 121 (1979) 497–498.
Müller, O., Rückert, U., Fabricius, K. Untersuchungen zur Exkretion von Cefaclor in menschlicher Galle. Infection 7 Suppl. 6 (1979) S 624-S 627.
Severn, M., Powis, S. J. A. Biliary excretions and tissue levels of cefuroxime. A study in eleven patients undergoing cholecystectomy. J. Antimicrob. Chemother. 5 (1979) 183–188.
Knothe, H., Dette, G. A. Antibiotika in der Klinik. Aesopus Verlag, Basel/München 1980, pp. 27–28.
Aeberhard, P. Indikationen für prophylaktische Antibiotika in der Chirurgie. Schweiz. Rundschau Med. (PRAXIS) 70 (1981) 452–457.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kees, F., Strehl, E., Dominiak, P. et al. Cefotaxime and desacetyl cefotaxime in human bile. Infection 11, 118–120 (1983). https://doi.org/10.1007/BF01641077
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01641077